CellGenix® Preclinical rh IL-12

Tech Support Documents
CellGenix® Preclinical rh IL-12 CellGenix® Preclinical rh IL-12 CellGenix® Preclinical rh IL-12
 
  • Recombinant Human Interleukin-12.
  • Optimal use for the proliferation of natural killer (NK) cells and differentiation of naive T cells towards Th1 effector cells.
  • ADCF Level 1.
  • High purity to ensure the safety of your process.
Quality Grade
Item No.: 
1428-050
Availability: 
*Custom/bulk order quotes are provided within 72 hours of request.

Choose your CellGenix® Growth Factors and Cytokines

See more products

CellGenix® Recombinant Human Interleukin-12 (IL-12) is an animal-derived component-free product.

IL-12 is used in the cell and gene therapy space for the ex vivo activation and expansion of T cells, including for CAR-T cell, NK cell, and TCR therapies.

Designed to meet the demands of translational research, CellGenix® preclinical cytokines are ideal to bridge the gap between the lower quality of research grade and the high cost of GMP grade materials.

Please access the Certificate of Analysis on the My Sartorius Portal.

Expiry: 3 years from date of shipping

Applications

  • Application Area
    Cell & gene therapy
  • Cell Type
    • NK Cells
    • T Cells
  • Intended Use
    Preclinical ex vivo use

Biological Information

  • Activity
    ≥ 2 × 10⁶ U/mg

Compliance Information

  • Origin
    Animal-Component Free
  • Quality Grade
    Preclinical

Physicochemical Information

  • Endotoxin
    ≤ 100 EU/mg
  • Expression System
    CHO

Product Information

  • Brand
    CellGenix®
  • Package Type
    Vial
  • Size
    50 µg

Sterility/Purity

  • Delivery Condition
    Sterile
  • Purity
    ≥ 95%

Weight

  • Molecular Weight (kDa)
    57.2 kDa
´